The advancement in cancer treatment, particularly in targeted therapies, relies heavily on the consistent availability of high-purity pharmaceutical intermediates. For manufacturers of Osimertinib, a groundbreaking drug for non-small-cell lung cancer (NSCLC) with EGFR mutations, understanding the sourcing of its key intermediate, 2,4-Dichloropyrimidine (CAS 3934-20-1), is critical. This article aims to guide procurement specialists and R&D professionals on effectively sourcing this vital compound.

The Role of 2,4-Dichloropyrimidine in Osimertinib Synthesis

2,4-Dichloropyrimidine serves as a foundational chemical scaffold in the multi-step synthesis of Osimertinib. Its specific structural features allow for the regioselective introduction of other molecular fragments, ultimately forming the complex structure of the API. The quality and purity of the 2,4-Dichloropyrimidine directly influence the yield and purity of the final Osimertinib product. Therefore, sourcing this intermediate from a reliable manufacturer is not just about cost, but about ensuring the efficacy and safety of the final drug product.

Identifying a Quality Supplier for Osimertinib Intermediate

When seeking to buy 2,4-Dichloropyrimidine specifically as an Osimertinib intermediate, several factors are paramount. Firstly, purity is key. Look for suppliers who provide assay results of 99% or higher via HPLC. Secondly, consistency in supply is crucial for uninterrupted manufacturing. A manufacturer with a proven track record and substantial production capacity is ideal. Many pharmaceutical companies opt to partner with Chinese manufacturers known for their chemical synthesis expertise and competitive pricing.

Key Features to Look For When Purchasing 2,4-Dichloropyrimidine:

  • CAS Number: Ensure the CAS number is accurately listed as 3934-20-1.
  • Appearance: Typically white to light yellow solid.
  • Purity: Guaranteed high purity (e.g., ≥99% HPLC).
  • Manufacturer Reputation: Established suppliers with good quality control.
  • Documentation: Availability of Certificate of Analysis (CoA) and other necessary quality documents.

Requesting samples from potential suppliers is a standard practice to verify the quality and suitability of the 2,4-Dichloropyrimidine for your specific synthesis route. Understanding the price dynamics, including bulk discounts, can also be a significant factor in cost management for your production.

Conclusion

For companies manufacturing Osimertinib, securing a reliable supply of 2,4-Dichloropyrimidine (CAS 3934-20-1) is a strategic imperative. By carefully selecting a manufacturer known for quality, consistency, and competitive pricing, pharmaceutical companies can ensure the efficient and effective production of this critical oncology medication. Partner with experienced suppliers to guarantee the integrity of your supply chain.